Patent · US Expired

Use of 3-indolepyruvic acid as a pharmaceutical agent for the inhibition of peripheral degenerative pathologies

US5075329A · kind A · utility

1Cited by

0References

5Claims

0Family size

Assignee

Polifarma S.p.A. · IT

Inventors

Vincenzo Politi · Roma, IT
Giovanni DiStazio · Roma, IT
Giovanna DeLuca · Roma, IT
Mario Materazzi · Roma, IT

Key dates

Filing date	Aug 17, 1989
Grant date	Dec 24, 1991
Priority date	—
Expiry date	Aug 17, 2009

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Indolepyruvic acid shows an inhibitory activity with respect to the degenerative action by oxygen free radical which are responsible for a number of pathologic conditions in various peripheral tissues. The compound can find application in miocardiopathies, inflammations, circulatory shock, arteriosclerosis, and cardiac ischemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.